Chargement en cours...
Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future
Constitutively activated prosurvival pathways render cancer cells addicted to their effects. Consequently they turn out to be the Achilles' heels whose inhibition can be exploited in anticancer therapy. Primary effusion lymphomas (PELs) are very aggressive non-Hodgkin's B cell lymphomas, w...
Enregistré dans:
| Publié dans: | Biomed Res Int |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324489/ https://ncbi.nlm.nih.gov/pubmed/25695042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/104912 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|